Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
22.4%
% of IBBQ's 196 holdings also in CNCR
61.1%
% of CNCR's 72 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 1.3% | 1.5% | 1.3% |
 |
EXELIXIS INC | 1.1% | 2.0% | 1.1% |
|
REGENERON PHARMACEUTICALS | 5.4% | 1.0% | 1.0% |
|
SUMMIT THERAPEUTICS INC | 1.4% | 1.0% | 1.0% |
|
REVOLUTION MEDICINES, INC. | 0.8% | 1.6% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to CNCR
|
GILEAD SCIENCES INC | 10.2% |
|
VERTEX PHARMACEUTICALS INC | 8.2% |
|
AMGEN INC | 7.1% |
|
REGENERON PHARMACEUTICALS | 4.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.4% |
|
ILLUMINA INC | 2.4% |
|
BIOGEN IDEC INC | 2.3% |
 |
ARGENX SE ADR | 2.1% |
|
UNITED THERAPEUTICS CORP | 1.7% |
IBBQ Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
REPLIMUNE GROUP, INC. | -1.8% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
SCHRODINGER, INC. | -1.7% |
|
XENCOR INC | -1.6% |
|
JANUX THERAPEUTICS, INC. | -1.6% |
|
ZYMEWORKS INC. | -1.6% |